MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories
Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z
  • Face Name matching and memory complaints in Parkinson’s disease

    A. Siquier, P. Andrés (Palma, Spain)

  • FACIAL EMOTION EXPRESSIVITY IN PARKINSON’S AND ALZHEIMER’S DISEASES

    A. Cannavacciuolo, A. Guerra, D. Colella, M. Salzillo, A. de Biase, G. Paparella, M. Canevelli, G. Bruno, A. Berardelli, M. Bologna (Pozzilli, Italy)

  • Facial emotion recognition in Parkinson’s disease: the role of executive and affective domains

    A. Siquier, P. Andrés (Palma, Spain)

  • Facial to diaphragmatic spasms: A tale of misfortune

    A. Singh, S. Shivangi, N. Bansal, R. Gupta, J. Singhvi, J. Kaur (Mohali, India)

  • Factors associated with progression of Parkinson’s disease and deterioration in quality of life: Results of J-FIRST, a 1-year observational study

    K. Kashihara, S. Chiu, Y. Tsuboi, N. Hattori, M. Nomoto, H. Watanabe, T. Maeda, H. Saiki, Y. Shimo, T. Yamaguchi (Okayama, Japan)

  • Factors related to the antidepressant effect of safinamide in Parkinson’s disease. A post-hoc analysis of SADNESS-PD study

    E. Peña, C. Borrué, M. Mata, JC. Martínez-Castrillo, A. Alonso-Canovas, JL. Chico, L. López-Manzanares, M. Llanero, J. Herreros-Rodríguez, A. Esquivel, T. Maycas-Cepeda, C. Ruíz-Huete (Madrid, Spain)

  • Factors that negatively impact the sexual function of men living with Parkinson’s disease

    B. de Souza (São Paulo, Brazil)

  • Factors that negatively impact the sexual function of women living with Parkinson’s disease

    K. Nobrega, R. Gonçalves, B. Silva, B. Souza, M. Piemonte (Macapa, Brazil)

  • Fall prevention in patients undergoing Magnetic resonance-guided focused ultrasound thalamotomy (MRgFUS thalamotomy) for refractory essential tremor (ET)

    T. Fay-Karmon, U. Kozlov, Y. Levitan, S. Anis, R. Spigelman, S. Israeli-Korn, S. Hassin-Baer, Z. Zivli (Ramat-Gan, Israel)

  • Fatigue at different stages of parkinson’s disease

    A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

  • FDG-PET features of Lewy body dementia among patients with amnestic presentations typical for Alzheimer’s disease

    J. Silva-Rodríguez, MA. Labrador-Espinosa, A. Moscoso, M. Schöll, P. Mir, M. Grothe (Sevilla, Spain)

  • Fear of progression is predicted by anxiety and self-efficacy but not disease-specific parameters in patients with Parkinson’s disease: data from a multicenter cross-sectional study

    AK. Folkerts, L. Haarmann, J. Nielsen, J. Saliger, M. Eschweiler, H. Karbe, N. Allert, V. Vida, C. Trenkwalder, A. Kruse, H. Oelsner, G. Ebersbach, E. Kalbe (Cologne, Germany)

  • Feasibility and acceptability of PDConnect: a collaborative approach to physical activity for people with Parkinson’s.

    J. Jones, L. Alexander, L. Hancock, K. Cooper (Aberdeen, United Kingdom)

  • Feasibility and efficacy of a multidisciplinary home-telehealth intervention program to reduce falls and improve quality of life in Parkinson´s disease. First results.

    A. García-Bustillo, A. Olivares-Gil, JL. Garrido-Labrador, JM. Ramírez-Sanz, A. Arnaiz-González, F. Valiñas-Sieiro, M. Allende-Río, JJ. González-Bernal, J. González-Santos, JF. Díez-Pastor, M. Jahouh, JM. Trejo-Gabriel-Galán, E. Cubo (Burgos, Spain)

  • Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease

    L. Rubin, M. Mccrossin, C. Claro, A. Persaud, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, P. Moondra, A. Di Rocco (Glen Cove, USA)

  • Feasibility of artificial intelligence in predicting early phenotype conversion of REM Sleep Behavior Disorder

    L. Lopes, P. Wu, J. Lu, J. Wang, C. Bassetti, A. Rominger, C. Zuo, H. Yu, K. Shi (Bern, Switzerland)

  • Feasibility of combining remote programming and remote monitoring towards a closed-loop DBS system

    ID. Bogdan, P. Kubben, M. Kuijf, E. Ross, Y. Pathak (Maastricht, Netherlands)

  • Feasibility of in-person and remote delivery of Alexander technique course for care partners of people with neurodegenerative disease

    M. Gross, R. Cohen, J. Bellingham, P. Brisset, C. Condie, S. Lazaro, B. Mello, A. Abdelrahman, J. Becker, S. Smith, T. Moote, W. Trusty (Candler, USA)

  • Feasibility of Sensor-Based Music Feedback In Patients With PD

    S. Mainka, G. Ebersbach (Beelitz-Heilstaetten, Germany)

  • Feasibility of telephonic voice samples to remotely monitor people with Parkinson’s disease residing in medically underserved rural regions

    A. Kemp, A. Iyer, A. Glover, L. Pillai, P. Farmer, Y. Rahmatallah, S. Syed, M. Lotia, L. Larson-Prior, F. Prior, T. Virmani (Little Rock, USA)

  • Feasibility of using ENROLL-HD for health services research: Evaluation of delays in Huntington’s Disease (HD) Diagnosis

    A. Mendizabal, S. Perlman, Y. Bordelon (LOS ANGELES, USA)

  • Feasibility of using mobile technology for aerobic exercise management in people with Parkinson’s disease

    MKY. Mak, LJ. Ren, ISK. Wong-Yu (Hong Kong SAR, China)

  • Feasibility of using wearable sensors to monitor activity and sleep patterns in inpatients with delirium and Parkinson’s disease

    G. Bate, S. Richardson, JP. Taylor, D. Burn, L. Allan, A. Yarnall, Y. Guan, S. Del-Din, R. Lawson (Newcastle-Upon-Tyne, United Kingdom)

  • Fever and syndrome of inappropriate antidiuretic hormone secretion induced by duloxetine intake in patient with multiple system atrophy

    J. Shi, L. Liu, J. Lin, M. Zhang, H. Liu, L. Xie (dalian, China)

  • Fibrinogen and CFAH: The two putative markers of Parkinson’s disease with cognitive impairment

    A. Naskar, S. M, S. Sengupta, P. Pal, P. Alladi (Bengaluru, India)

  • Finely tuned gamma oscillations across the motor system in patients with isolated dystonia implanted with sensing-enabled pulse generators

    S. Cernera, M. Olaru, C. Oehrn, S. Little, P. Starr (San Francisco, USA)

  • Fingolimod-responsive complex hyperkinetic movement disorder in neuromyelitis optica spectrum disorder

    RE. Cortes, JA. Vatanagul, G. Saranza (Cebu, Philippines)

  • Five for the price of one- A multidirectional micro-electrode recordings for DBS Surgery

    A. Socher, I. Strauss, A. Tankus, A. Hillel, G. Maayan, G. Morris, H. Bergman, T. Gurevich (Tel Aviv, Israel)

  • Focused ultrasound offers tremor relief in multiple system atrophy patients

    M. Nassar, A. Sinai, L. Shornikov, I. Erikh, M. Constantinescu, M. Zaaroor, I. Schlesinger (Haifa, Israel)

  • Focused Ultrasound Subthalamotomy in Parkinson’s Disease: Lesion Topography and Motor Improvement.

    J. Mañez-Miro, R. Rodríguez-Rojas, J. Pineda-Pardo, M. Del álamo, R. Martinez-Fernandez, J. Obeso (MOSTOLES, Spain)

  • Fragile X Associated Tremor and Ataxia Syndrome (FXTAS) presents with widespread reactive gliosis and white-matter specific astrocyte degeneration

    B. Dufour, V. Martínez-Cerdeño (Sacramento, USA)

  • Freezing of Gait Can Predict Cognitive Decline in Parkinson’s Disease

    Y. Qu, JT. Li, YP. Chen, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

  • Frequency dependent interindividual variability of the deep brain stimulation effect on upper-limb bradykinesia

    P. Dorin, D. Brogle, S. Hägele-Link, M. Krüger, G. Kägi, F. Brugger (St. Gallen, Switzerland)

  • Frequency of depression and predictors of mood change among caregivers of Parkinson’s disease patients

    C. Iñiguez Alvarado, D. Santos García, T. Deus Fonticoba, C. Cores, M. Feal Painceiras, E. Suarez Castro, C. Martinez Miró, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldente, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. ávila Rivera, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. García-Soto, C. Borrué, B. Solano Vila, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez Estrada, M. Seijo, J. Rúiz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González Ardura, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martinez-Martin, P. Mir (A Coruña, Spain)

  • Frequency of non- motor symptoms in dystonia patients

    V. Vuletic (Rijeka, Croatia)

  • Frequency of non-motor symptoms in GBA-PD may differ in carriers of mild vs. severe pathogenic variants

    T. Usnich, N. Brüggemann, M. Olmedillas, N. Schell, I. Csoti, S. Ertan, D. Gruber, S. Zittel, E. Sammler, S. Isaacson, A. Kühn, D. Pedrosa, K. Reetz, A. Sah, M. Kasten, P. Bauer, C. Klein (Lübeck, Germany)

  • Frequency-specific dynamics of beta oscillations: Critical for tuning adaptive DBS

    LC. Alva, F. Torrecillos, A. Averna, E. Bernasconi, M. Bange, A. Mostofi, A. Pogosyan, P. Fischer, M. Muthuraman, K. Ashkan, S. Groppa, EA. Pereira, H. Tan, G. Tinkhauser (Bern, Switzerland)

  • Functional dystonia on a 46 year-old woman

    F. Rivas, I. Rodríguez, D. Vázquez (San Luis Potosí, Mexico)

  • Functional Movement Disorder Comorbidity in Parkinson’s Disease: a Multicenter Descriptive Study in Spain

    C. Delgado, A. Lopez, E. Lopez, V. Gomez, A. Baltasar, JC. Martinez, A. Alonso, G. Tabar, PJ. Garcia, S. de Lafuente, L. Vela, I. Pareés, M. Kurtis (Madrid, Spain)

  • Functional movement disorder with mixed phenotype in a child with Asperger’s syndrome

    K. Salinas-Barboza, R. Huerta-Albarrán, JM. Altamirano (Mexico City, Mexico)

  • Functional MRI and gait analysis characteristics in patients with idiopathic rem sleep behavior disorder

    E. Sarasso, A. Gardoni, S. Marelli, L. Zenere, A. Castelnuovo, A. Tettamanti, L. Ferini-Strambi, M. Filippi, F. Agosta (Milano, Italy)

  • Functional Rating Scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington’s disease: The importance of the patient voice in scale development

    R. Fuller, P. Feigenbaum, N. Lapelle, S. Sathe, C. Fitzer-Attas, M. Guttman, C. Goetz, S. Luo, B. Tilley, P. Dalal, C. Sampaio, G. Stebbins (Princeton, USA)

  • Functional validation of a mitochondria-specific polygenic risk score in patient-based models for stratification of idiopathic Parkinson’s disease

    G. Arena, Z. Landoulsi, A. Vitali, S. Delcambre, P. Antony, I. Boussaad, L. Pavelka, M. Sharma, E. Glaab, D. Grossmann, A. Grünewald, P. May, R. Krüger (Esch-sur-Alzette, Luxembourg)

  • Fundamental changes in Nerve Conduction Velocity and hyperpolarization latency of action potential of Sciatic nerve at the pre-motor phase in a chronic PD in vivo model: a neurotool for Parkinson’s disease diagnosis

    I. Datta, K. Mondal, A. Kaushal (Bengaluru, India)

  • Funding and Sustainability Challenges in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease

    C. Gonzalez-Robles, J. Ahmed, C. Bale, R. Chapman, S. Clegg, E. Deeson, R. Ellis-Doyle, V. Greaves, J. Handley, E. Henderson, K. Matthews, S. Medd-Phillips, L. Miller, G. Mills, J. Rudiger, ML. Zeissler, C. Carroll, T. Foltynie, S. Gandhi, J. Duffen (London, United Kingdom)

Jump to:  View All • a b c d e [f] g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
        • Help & Support
        • About Us
        • Cookies & Privacy
        • Wiley Job Network
        • Terms & Conditions
        • Advertisers & Agents
        Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
        Wiley